Feedback from patients and hospital employees has been positive. Participants appreciated the ability to manage their health without frequent clinic visits, which often require taking time off work or traveling long distances. Healthcare providers, in turn, received more accurate patient data remotely, as clinic visits can sometimes lead to artificially high readings due to anxiety.
With the trial expanding beyond the initial 27 patients, Koomson and her team plan to adapt the AHOMKA app for multiple mobile operating systems. They are also working with a software development team based in Ghana to address any issues promptly. Future updates may include features for patients to upload medical information, such as blood tests, and access chatbot support for health inquiries.
Additionally, plans are underway to integrate a text messaging system for individuals without smartphones, broadening accessibility. Koomson envisions further applications of the platform, including support for patients living with sickle-cell disease, a prevalent condition in sub-Saharan Africa.
MEDICA-tradefair.com; Source: Tufts University